摘要
目的探讨沐舒坦佐治小儿肺炎的临床疗效。方法240例肺炎患儿随机分为观察组和对照组,均予常规抗感染、止咳平喘治疗,观察组加用沐舒坦。结果观察组临床症状及体征消退时间、住院天数较对照组明显缩短(P<0.01),5 d和7 d内炎症基本吸收率高于对照组(P<0.01或0.05)。结论沐舒坦对小儿肺炎具有辅佐治疗作用。
Objective To explore the therapeutic effect of Mucosolvan as an adjunct to antibiotics for pediatric pneumonia. Methods 240 children with pneumonia were randomly divided into two groups： treatment group and control group. All the children were treated with antibiotics and medications for relieving cough and smoothing asthma. Children in treatment group were added Mueosolvan for an adjuvant therapy. Results Compared with children in control group, children in treatment group bed a quicker subsiding of clinical symptoms and signs and a shorter hospital stay time （ P 〈 0.01, P 〈 0.05） , and the high rate of inflammatory absorption in 5 d and 7 d（P 〈 0.01 , P 〈 0.05 ）. Conclusion Mucosolvan had a certain adjuvant therapeutic effect on pediatric pneumonia.
出处
《健康研究》
CAS
2009年第1期37-38,共2页
Health Research
关键词
沐舒坦
肺炎
Mucosolvan
pediatric pneumonia
